Four details:
1. FemSelect, an Israeli medtech company, designed EnPlace for vaginal colpopexy by sacrospinous ligament fixation.
2. CMS created the CPT code (C9778: Colpopexy, minimally invasive, extraperitoneal) following a review of the company’s New Technology Ambulatory Payment Classification, which outlines services or procedures “new and significant enough to warrant having a unique code under the Healthcare Common Procedure Coding System,” according to the agency.
3. EnPlace is positioned for appropriate payment as a level 5 GYN procedure and designated as device intensive, which increases access to the procedure in the ASC setting, CMS said in a Nov. 10 news release.
4. Pelvic organ prolapse is a condition in which one or more female pelvic floor organs descend, with symptoms including discomfort, embarrassment and urinary and sexual dysfunction. Half of women older than 50 suffer from a pelvic floor condition, according to FemSelect.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
